> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA/Aetion Oncology RWD Research
- URL: https://www.fdaweb.com/fda-aetion-oncology-rwd-research/
- Published: 2023-01-25T12:00:00.000Z
- Updated: 2026-09-14T18:13:08.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153620

The FDA Oncology Center of Excellence will have a five-year collaboration with Aetion to advance research using novel oncology real-world data (RWD) sources through platform analytics on the Aetion Evidence Platform. Aetion [says](https://aetion.com/company/news/aetion-fda-oncology-rwd/?ref=fdaweb.com) it and the agency will use the evidence platform to identify and analyze fit-for-purpose RWD sources to address key research questions that are relevant to prevention, clinical care, diagnostics, and treatment in oncology.

The research objectives, Aetion says, include addressing real-world endpoints, evaluation of causal inference methods, and measuring and understanding health disparities to advance health equity.